SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:uu-100754"
 

Search: id:"swepub:oai:DiVA.org:uu-100754" > Metabolism of a nov...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Metabolism of a novel side chain modified Delta 8(14)-15-ketosterol, a potential cholesterol lowering drug : 28-hydroxylation by CYP27A1

Pettersson, Hanna (author)
Uppsala universitet,Avdelningen för farmaceutisk biokemi,Steroid P450
Norlin, Maria (author)
Uppsala universitet,Avdelningen för farmaceutisk biokemi,Steroid P450
Andersson, Ulla (author)
Avd. för klinisk kemi, KI, Huddinge, Sverige
show more...
Pikuleva, Irina (author)
Department of clinical chemistry and toxicology, University of Texas medical branch, Galveston, USA
Björkhem, Ingemar (author)
Karolinska Institutet
Misharin, Alexander Yu (author)
Inst. of biomedical chemisrty, Russian academy of medical sciences, Moscow, Russia
Wikvall, Kjell (author)
Uppsala universitet,Avdelningen för farmaceutisk biokemi,Steroid P450
show less...
 (creator_code:org_t)
Elsevier BV, 2008
2008
English.
In: Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids. - : Elsevier BV. - 1388-1981 .- 1879-2618. ; 1781:8, s. 383-390
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The synthetic inhibitors of sterol biosynthesis, 3beta-hydroxy-5alpha-cholest-8(14)-en-15-one and 3beta-hydroxy-24S-methyl-5alpha-cholesta-8(14),22-dien-15-one, are of interest as potential cholesterol lowering drugs. Rapid metabolism of synthetic 15-ketosterols may lead to a decrease, or loss, of their potency to affect lipid metabolism. 3beta-Hydroxy-5alpha-cholest-8(14)-en-15-one is reported to be rapidly side chain oxygenated by rat liver mitochondria. In an attempt to reduce this metabolism, the novel side chain modified 15-ketosterol 3beta-Hydroxy-24S-methyl-5alpha-cholesta-8(14),22-dien-15-one was synthesized. We have examined the metabolism by recombinant human CYP27A1 of this novel side chain modified 3beta-hydroxy-24S-methyl-5alpha-cholesta-8(14),22-dien-15-one and compared the rate of metabolism with that of the previously described 3beta-hydroxy-5alpha-cholest-8(14)-en-15-one. Both sterols were found to be efficiently metabolized by recombinant human CYP27A1. None of the two 15-ketosterols was significantly metabolized by microsomal 7alpha-hydroxylation. Interestingly, CYP27A1-mediated product formation was much lower with the side chain modified 3beta-hydroxy-24S-methyl-5alpha-cholesta-8(14),22-dien-15-one than with the previously described 3beta-hydroxy-5alpha-cholest-8(14)-en-15-one. A surprising finding was that this novel side chain modified sterol was metabolized mainly in the C-28 position by CYP27A1. The data on 28-hydroxylation by human CYP27A1 provide new insights on the catalytic properties and substrate specificity of this enzyme. The finding that 3beta-hydroxy-24S-methyl-5alpha-cholesta-8(14),22-dien-15-one with a modified side chain is metabolized at a dramatically slower rate than the previously described 15-ketosterol with unmodified side chain may be important for future development of synthetic cholesterol lowering sterols.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Farmaceutiska vetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Pharmaceutical Sciences (hsv//eng)

Keyword

human CYP27A1
27-hydroxylation
28-hydroxylation
inhibitors of sterol biosynthesis
cholesterol lowering drug
Pharmaceutical biochemistry
Farmaceutisk biokemi
Biokemi
Biochemistry

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view